ACHE and Alzheimer disease: The treatment period for these AChEIs is constrained because to the extensive damage to neurons in AD patients, resulting in AChE levels being permanently diminished by over 90%, although BChE levels may grow to 120% of the physiological norm.11 BChE serves a vital function as a compensatory enzyme in the progression of AD.